{"cik":"0000744218","ticker":"CLDX","name":"Celldex Therapeutics, Inc.","sic_code":"2835","sic_description":"In Vitro & In Vivo Diagnostic Substances","exchange":"Nasdaq","state_of_incorporation":"DE","fiscal_year_end":"1231","first_filing_date":"2026-05-15","last_filing_date":"2026-07-15","url":"/sec/cik-0000744218","insider_summary":{"total_transactions":18,"unique_insiders":18,"latest_transaction":"2026-06-25"},"recent_filings":[{"accession_number":"0001104659-26-109465","form_type":"8-K","form_type_family":"current","doc_date":"2026-09-22","title":"8-K — Celldex Therapeutics, Inc. — 2026-09-22","url_slug":"/sec/cik-0000744218/8-k/0001104659-26-109465","edgar_url":"https://www.sec.gov/Archives/edgar/data/744218/0001104659-26-109465-index.html"},{"accession_number":"0000080255-26-000537","form_type":"SCHEDULE 13G","form_type_family":"other","doc_date":"2026-08-14","title":"SCHEDULE 13G — Celldex Therapeutics, Inc. — 2026-08-14","url_slug":"/sec/cik-0000744218/schedule-13g/0000080255-26-000537","edgar_url":"https://www.sec.gov/Archives/edgar/data/744218/0000080255-26-000537-index.html"},{"accession_number":"0001171843-26-005316","form_type":"8-K","form_type_family":"current","doc_date":"2026-08-06","title":"8-K — Celldex Therapeutics, Inc. — 2026-08-06","url_slug":"/sec/cik-0000744218/8-k/0001171843-26-005316","edgar_url":"https://www.sec.gov/Archives/edgar/data/744218/0001171843-26-005316-index.html"},{"accession_number":"0001104659-26-091984","form_type":"10-Q","form_type_family":"quarterly","doc_date":"2026-08-06","title":"10-Q — Celldex Therapeutics, Inc. — 2026-08-06","url_slug":"/sec/cik-0000744218/10-q/0001104659-26-091984","edgar_url":"https://www.sec.gov/Archives/edgar/data/744218/0001104659-26-091984-index.html"},{"accession_number":"0001104659-26-083880","form_type":"8-K","form_type_family":"current","doc_date":"2026-07-15","title":"8-K — Celldex Therapeutics, Inc. — 2026-07-15","url_slug":"/sec/cik-0000744218/8-k/0001104659-26-083880","edgar_url":"https://www.sec.gov/Archives/edgar/data/744218/0001104659-26-083880-index.html"},{"accession_number":"0001518575-26-000002","form_type":"4","form_type_family":"insider","doc_date":"2026-06-29","title":"4 — Brownlie Keith L — 2026-06-29","url_slug":"/sec/cik-0001518575/4/0001518575-26-000002","edgar_url":"https://www.sec.gov/Archives/edgar/data/744218/0001518575-26-000002-index.html"},{"accession_number":"0001104659-26-078233","form_type":"S-8","form_type_family":"other","doc_date":"2026-06-26","title":"S-8 — Celldex Therapeutics, Inc. — 2026-06-26","url_slug":"/sec/cik-0000744218/s-8/0001104659-26-078233","edgar_url":"https://www.sec.gov/Archives/edgar/data/744218/0001104659-26-078233-index.html"},{"accession_number":"0001104659-26-078023","form_type":"8-K","form_type_family":"current","doc_date":"2026-06-26","title":"8-K — Celldex Therapeutics, Inc. — 2026-06-26","url_slug":"/sec/cik-0000744218/8-k/0001104659-26-078023","edgar_url":"https://www.sec.gov/Archives/edgar/data/744218/0001104659-26-078023-index.html"}],"related_endpoints":{"profile":"/sec/CLDX/profile","timeline":"/sec/CLDX/timeline","peers":"/sec/CLDX/peers","insider_pulse":"/sec/CLDX/insider-pulse","insider_summary":"/sec/CLDX/insider-summary","insider_transactions":"/sec/CLDX/insider-transactions","form144":"/sec/CLDX/form144","holdings_as_filer":"/sec/CLDX/holdings","financial_facts":"/sec/CLDX/financial-facts","derivatives":"/sec/CLDX/derivatives","officers":"/sec/CLDX/officers","insider_network":"/sec/CLDX/insider-network","risk_flags":"/sec/CLDX/risk-flags","filings":"/sec/CLDX/filings","cross_topic_dossier":"/api/v1/dossier?ticker=CLDX"}}